PRODUCT LITERATURE

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and classifiable epilepsy: an unblinded randomised controlled trial

---

Valproate is widely accepted as a drug of first choice for patients with generalised onset seizures, and its broad spectrum of efficacy means it is recommended for patients with seizures that are difficult to classify. Lamotrigine and topiramate are also thought to possess broad spectrum activity.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Procifer

Specific Detail Info

Lancet. 2007 March 24; 369(9566): 1016–1026

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment